NCT06676137 An Observational Study of Coronary Microvascular Disease of China
| NCT ID | NCT06676137 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Henan Institute of Cardiovascular Epidemiology |
| Condition | Coronary Microvascular Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-11-11 |
| Primary Completion | 2028-10-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-11-11 with a primary completion date of 2028-10-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Non-obstructive coronary heart disease refers to patients with angina pectoris without significant narrowing of the epicardial vessels. Coronary microvascular disease(CMD) is a kind of non-obstructive coronary heart disease, and its clinical detection rate is increasing, seriously affecting the quality of life of patients, and increasing the risk of cardiovascular adverse events, but its mechanism has not been fully understood. This study will prospectively collect patients who meet the diagnosis of CMD, observe the development and outcome of the disease, and explore its occurrence and development mechanism.
Eligibility Criteria
Inclusion Criteria: 1. Angina symptoms 2. Objective evidence of myocardial ischemia 3. Coronary angiography was normal,irregular tube wall, or stenosis \<50% Exclusion Criteria: 1. People under the age of 18 2. Non-cardiogenic chest pain and other heart conditions such as variant angina, cardiomyopathy, myocarditis or valvular heart disease
Contact & Investigator
muwei li, Ph.D
STUDY CHAIR
Fuwai central China cardiovascular hospotial
Frequently Asked Questions
Who can join the NCT06676137 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Coronary Microvascular Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06676137 currently recruiting?
Yes, NCT06676137 is actively recruiting participants. Contact the research team at xinyiguoquan@163.com for enrollment information.
Where is the NCT06676137 trial being conducted?
This trial is being conducted at Zhengzhou, China.
Who is sponsoring the NCT06676137 clinical trial?
NCT06676137 is sponsored by Henan Institute of Cardiovascular Epidemiology. The principal investigator is muwei li, Ph.D at Fuwai central China cardiovascular hospotial. The trial plans to enroll 500 participants.